Celecoxib N-des(benzenesulfonamide) is a pharmaceutical intermediate impurity, specifically a de-sulfonylated derivative of celecoxib. It is a chemical compound primarily encountered in the context of pharmaceutical manufacturing and quality control.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 948293-46-7
4,6-Dichloro-2-(propylsulfanyl)pyrimidine
Pharmaceutical intermediate impurity
Ethyl 4-bromo-3-(ethoxymethyl)benzoate
Pharmaceutical intermediate
((2R,3R,4R,5R)-5-(2-Amino-7-methyl-6-oxo-3,6-dihydro-9H-purin-7-ium-9-yl)-3-hydroxy-4-methoxytetrahydrofuran-2-yl)methyl hydrogen phosphate
RNA modification intermediate
1-Benzyl-4-piperidone oxime
pharmaceutical intermediate
3-Benzoyl-2-(4-methoxyphenyl)-4-phenyloxazolidine-5-carboxylic acid, (4S,5R)-
Pharmaceutical intermediate for paclitaxel
2-Chloro-4-(1H-pyrazol-3-yl)benzonitrile
pharmaceutical intermediate
(S)-4-(1-(2-aminopropyl)-1H-pyrazol-3-yl)-2-chlorobenzonitrile
Pharmaceutical intermediate for darolutamide
Tert-Butyl (S)-(1-(3-(3-chloro-4-cyanophenyl)-1H-pyrazol-1-yl)propan-2-yl)carbamate
Pharmaceutical intermediate
3-(4-methylphenyl)-5-(trifluoromethyl)-1H-pyrazole
NQEFIPVOJGJVRG-UHFFFAOYSA-N
CC1=CC=C(C=C1)C2=NNC(=C2)C(F)(F)F